Houlihan Lokey Advises TA Associates

Houlihan Lokey is pleased to announce that TA Associates (TA) has acquired a significant stake in OmniActive Health Technologies (OmniActive). The transaction closed on January 11, 2021.

Established in 2005, OmniActive seeks to improve lives by enhancing nutrition and wellness through science and innovation. A leader in health solutions, the company offers a range of premium natural ingredients that are innovative and scientifically validated for dietary supplementation and nutritional fortification. OmniActive is committed to partnering with customers globally to improve the health and well-being of consumers. It has R&D and manufacturing operations in Pune, Hosur, and Thane, India, and sales and distribution operations in the U.S., Europe, India, Asia, Australia, and Latin America. OmniActive is headquartered in Mumbai, India.

TA is a leading global-growth private equity firm. Focused on targeted sectors within five industries—technology, healthcare, financial services, consumer, and business services—the company invests in profitable, growing companies with opportunities for sustained growth and has invested in more than 500 companies around the world. Investing as either a majority or minority investor, TA employs a long-term approach, utilizing its strategic resources to help management teams build lasting value in high-quality growth companies. It has raised $33.5 billion in capital since its founding in 1968 and is committing to new investments at the pace of more than $3 billion per year. TA’s more than 100 investment professionals are based in Boston, Menlo Park, London, Mumbai, and Hong Kong.

This deal represents another successful transaction for Houlihan Lokey in the consumer, food, and retail industry.